Solid Dosage
GEA supplies highly specialized solutions for manufacturing inhalable drugs ranging from dry powder blending, spray drying to particle engineering capabilities.
Inhalables and aerosols, no matter whether they are in liquid or solid form, must be delivered to the oral cavity or the greater respiratory system.
Inhalation is often the preferred drug delivery method for lung diseases, offering a number of advantages for both patients and medical professionals for the administration of vaccines and other biological drugs. Producing powders for inhalation is relatively straightforward on a small scale; but, it can be hard to replicate at a commercial level.
To facilitate the process, GEA has developed a highly specialized spray drying system that offers large-scale particle engineering capabilities. This makes it possible to accurately manipulate the aerodynamic size and flow properties of particles to produce fine, free-flowing powders for applications such as commercializing biological compounds including hormones, peptides and proteins that risk degradation if ingested.
When it comes to mixing and blending very fine powders, homogeneity and stability are key factors during the production of inhalable drugs. As such, GEA also offers production-scale mixing and blending solutions to produce inhalable products (dry powders and suspensions).
The TRV high-speed blender, a standalone PharmaConnect® module, is particularly suitable for the rapid batch blending of small quantities of APIs with base excipients. By combining the high surface area of the main impeller blade with the directional effects of the feeder blade, rapid, homogenous and stable blends can be produced in a reproducible manner.
Wyświetlane elementy: 4 z 15
Połączenie monitorowania procesu z analizatorami w linii wraz z solidnymi zasadami projektowania procesu i zaawansowanymi technikami modelowania procesu umożliwi aktywne sterowanie procesem w celu kompensacji zmian sygnału wejściowego.
Contained Materials Handling solutions for Primary and Secondary Pharmaceuticals and Healthcare. With extensive experience within the generics sector, supply a wide range of technologies and equipment that improve and enhance the efficiency and performance of Oral Solid Dosage production.
The ConsiGma® DC for direct compression is the latest expansion of GEA's continuous portfolio for cost effective, compact, high yield manufacturing systems. It offers a robust and flexible manufacturing method for a wide range of products.
Continuous Processing is becoming more and more important in the pharmaceutical industry. GEA takes the lead in introducing this innovative technology with ConsiGma® - continuous high-shear granulation and drying lines.
Badacze i projektanci z branży biofarmaceutycznej, spożywczej oraz segmentu nowej żywności dostają do ręki nowe narzędzie: potężny akcelerator najnowszej generacji GEA kytero 10.
Życie Michele Schneider zmieniło się w sposób niespodziewany, gdy jej mężem został Virlei, ambitny hodowca była mlecznego i gdy razem założyli w Brazylii gospodarstwo mleczne Fazenda Inovação Schneider Milk. Jako nowicjuszka w branży produkcji mleka, Michele szybko rozwinęła pasję do zwierząt i prowadzenia gospodarstwa. Zwiększyło się także jej obciążenie pracą.
GEA pomaga klientom testować i rozwijać alternatywne produkty i składniki jajeczne wytwarzane przy użyciu precyzyjnej fermentacji.